Process View
A cascade of processes initiated in response to the detection of DNA damage, and resulting in the induction of transcription.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "dna damage response signal transduction resulting in transcription"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.626 | ||
| EP300 | E1A binding protein p300 | 0.553 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.550 | ||
| CREBBP | CREB binding protein | 0.512 | ||
| TP53 | tumor protein p53 | 0.440 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.392 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.391 | ||
| CCNE1 | cyclin E1 | 0.355 | ||
| BRCA1 | breast cancer 1, early onset | 0.335 | ||
| DAXX | death-domain associated protein | 0.330 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.321 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.234 | ||
| WWOX | WW domain containing oxidoreductase | 0.189 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.153 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.148 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.143 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.126 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.111 | ||
| BARD1 | BRCA1 associated RING domain 1 | 0.108 | ||
| PML | promyelocytic leukemia | 0.077 | ||
| LIMD1 | LIM domains containing 1 | 0.061 | ||
| RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.054 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.050 | ||
| RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.048 | ||
| CREB1 | cAMP responsive element binding protein 1 | 0.048 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.047 | ||
| DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.045 | ||
| MAPK8IP2 | mitogen-activated protein kinase 8 interacting protein 2 | 0.045 | ||
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.042 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.042 | ||
| CDC25B | cell division cycle 25 homolog B (S. pombe) | 0.039 | ||
| COASY | CoA synthase | 0.038 | ||
| IFI44L | interferon-induced protein 44-like | 0.038 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.037 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.036 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.034 | ||
| ATM | ataxia telangiectasia mutated | 0.034 | ||
| TOX4 | TOX high mobility group box family member 4 | 0.034 | ||
| MKRN1 | makorin ring finger protein 1 | 0.034 | ||
| UBE2C | ubiquitin-conjugating enzyme E2C | 0.033 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.032 | ||
| PLK1 | polo-like kinase 1 | 0.032 | ||
| NMI | N-myc (and STAT) interactor | 0.031 | ||
| SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.031 | ||
| USP42 | ubiquitin specific peptidase 42 | 0.029 | ||
| SP1 | Sp1 transcription factor | 0.027 | ||
| DCAF7 | DDB1 and CUL4 associated factor 7 | 0.027 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.027 | ||
| RNF19A | ring finger protein 19A | 0.026 | ||
| SPRED1 | sprouty-related, EVH1 domain containing 1 | 0.024 | ||
| IFI16 | interferon, gamma-inducible protein 16 | 0.023 | ||
| CABLES1 | Cdk5 and Abl enzyme substrate 1 | 0.023 | ||
| DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 0.022 | ||
| LIMK2 | LIM domain kinase 2 | 0.022 | ||
| CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.022 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.022 | ||
| RB1 | retinoblastoma 1 | 0.021 | ||
| KRT5 | keratin 5 | 0.020 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.020 | ||
| POLD1 | polymerase (DNA directed), delta 1, catalytic subunit 125kDa | 0.019 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.019 | ||
| AKT1S1 | AKT1 substrate 1 (proline-rich) | 0.018 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.018 | Human | |
| MEST | mesoderm specific transcript homolog (mouse) | 0.018 | ||
| SATB2 | SATB homeobox 2 | 0.018 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.018 | ||
| SPRR2A | small proline-rich protein 2A | 0.018 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.017 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.017 | ||
| ISG15 | ISG15 ubiquitin-like modifier | 0.017 | ||
| BANP | BTG3 associated nuclear protein | 0.017 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.016 | ||
| PIAS2 | protein inhibitor of activated STAT, 2 | 0.016 | ||
| CUL7 | cullin 7 | 0.016 | ||
| PTPRR | protein tyrosine phosphatase, receptor type, R | 0.016 | ||
| PHF11 | PHD finger protein 11 | 0.016 | ||
| REV3L | REV3-like, catalytic subunit of DNA polymerase zeta (yeast) | 0.016 | ||
| SP100 | SP100 nuclear antigen | 0.016 | ||
| C19orf46 | chromosome 19 open reading frame 46 | 0.016 | ||
| VPS72 | vacuolar protein sorting 72 homolog (S. cerevisiae) | 0.015 | ||
| CDC25A | cell division cycle 25 homolog A (S. pombe) | 0.015 | ||
| PRKCA | protein kinase C, alpha | 0.015 | ||
| MYST3 | MYST histone acetyltransferase (monocytic leukemia) 3 | 0.015 | ||
| DUSP3 | dual specificity phosphatase 3 | 0.015 | ||
| OTUB1 | OTU domain, ubiquitin aldehyde binding 1 | 0.015 | ||
| MX2 | myxovirus (influenza virus) resistance 2 (mouse) | 0.015 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.014 | ||
| SAMD9 | sterile alpha motif domain containing 9 | 0.014 | ||
| KRT6C | keratin 6C | 0.014 | ||
| CDT1 | chromatin licensing and DNA replication factor 1 | 0.014 | ||
| MAGEA2 | melanoma antigen family A, 2 | 0.014 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.014 | ||
| NQO1 | NAD(P)H dehydrogenase, quinone 1 | 0.014 | ||
| DMAP1 | DNA methyltransferase 1 associated protein 1 | 0.013 | ||
| SPTBN4 | spectrin, beta, non-erythrocytic 4 | 0.013 | ||
| ARIH2 | ariadne homolog 2 (Drosophila) | 0.013 | ||
| NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.013 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.012 | ||
| S100A4 | S100 calcium binding protein A4 | 0.012 | ||
| TPT1 | tumor protein, translationally-controlled 1 | 0.012 | ||
| GLUL | glutamate-ammonia ligase | 0.012 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.012 | ||
| C10orf116 | chromosome 10 open reading frame 116 | 0.012 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.012 | ||
| MEN1 | multiple endocrine neoplasia I | 0.011 | ||
| CCND3 | cyclin D3 | 0.011 | ||
| CBLC | Cas-Br-M (murine) ecotropic retroviral transforming sequence c | 0.011 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.011 | ||
| DHX34 | DEAH (Asp-Glu-Ala-His) box polypeptide 34 | 0.011 | ||
| PSRC1 | proline/serine-rich coiled-coil 1 | 0.011 | ||
| MAPT | microtubule-associated protein tau | 0.010 | ||
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.010 | ||
| CFL1 | cofilin 1 (non-muscle) | 0.010 | ||
| DUSP7 | dual specificity phosphatase 7 | 0.010 | ||
| IP6K2 | inositol hexakisphosphate kinase 2 | 0.010 |